Header cover image

Malaysian (KLSE) Clinical Research and Equipment Industry Analysis

UpdatedMay 19, 2025
DataAggregated Company Financials
Companies1
  • 7D-1.9%
  • 3M-21.2%
  • 1Y-40.9%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has risen 11%, driven by gains from every company within the industry. In the past year, the industry is down 37%.

Industry Valuation and Performance

Has the Malaysian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 19 May 2025RM 35.7mRM 5.8m-RM 4,163,000.00n/a-8.6x6.2x
Wed, 16 Apr 2025RM 25.4mRM 5.8m-RM 4,163,000.00n/a-6.1x4.4x
Fri, 14 Mar 2025RM 35.7mRM 5.8m-RM 4,163,000.00n/a-8.6x6.2x
Sun, 09 Feb 2025RM 42.5mRM 8.9m-RM 7,376,906.00n/a-5.8x4.8x
Tue, 07 Jan 2025RM 48.0mRM 8.9m-RM 7,376,906.00n/a-6.5x5.4x
Thu, 05 Dec 2024RM 47.3mRM 8.9m-RM 7,376,906.00n/a-6.4x5.3x
Sat, 02 Nov 2024RM 46.0mRM 9.7m-RM 7,896,906.00n/a-5.8x4.7x
Mon, 30 Sep 2024RM 48.7mRM 9.7m-RM 7,896,906.00n/a-6.2x5x
Wed, 28 Aug 2024RM 50.8mRM 10.7m-RM 17,594,906.00n/a-2.9x4.8x
Fri, 26 Jul 2024RM 54.9mRM 10.7m-RM 17,594,906.00n/a-3.1x5.1x
Sun, 23 Jun 2024RM 56.3mRM 10.7m-RM 17,594,906.00n/a-3.2x5.3x
Tue, 21 May 2024RM 56.3mRM 9.6m-RM 19,048,906.00n/a-3x5.9x
Thu, 18 Apr 2024RM 57.6mRM 9.6m-RM 19,048,906.00n/a-3x6x
Sat, 16 Mar 2024RM 60.4mRM 9.6m-RM 19,296,000.00n/a-3.1x6.3x
Mon, 12 Feb 2024RM 61.1mRM 8.4m-RM 14,246,000.00n/a-4.3x7.3x
Wed, 10 Jan 2024RM 61.7mRM 8.4m-RM 14,246,000.00n/a-4.3x7.4x
Fri, 08 Dec 2023RM 63.1mRM 8.4m-RM 14,246,000.00n/a-4.4x7.5x
Sun, 05 Nov 2023RM 62.4mRM 8.4m-RM 14,246,000.00n/a-4.4x7.5x
Tue, 03 Oct 2023RM 65.9mRM 8.4m-RM 14,246,000.00n/a-4.6x7.9x
Thu, 31 Aug 2023RM 58.3mRM 8.4m-RM 14,246,000.00n/a-4.1x7x
Sat, 29 Jul 2023RM 61.7mRM 12.5mRM 781.0k79.1x79.1x5x
Mon, 26 Jun 2023RM 59.9mRM 12.5mRM 781.0k76.7x76.7x4.8x
Wed, 24 May 2023RM 67.7mRM 16.9mRM 5.6m12.1x12.1x4x
Fri, 21 Apr 2023RM 71.6mRM 16.9mRM 5.6m12.8x12.8x4.2x
Sun, 19 Mar 2023RM 71.6mRM 16.9mRM 5.6m12.8x12.8x4.2x
Tue, 14 Feb 2023RM 95.1mRM 22.9mRM 7.8m12.2x12.2x4.2x
Thu, 12 Jan 2023RM 100.3mRM 22.9mRM 7.8m12.8x12.8x4.4x
Sat, 10 Dec 2022RM 102.9mRM 22.9mRM 7.8m13.2x13.2x4.5x
Mon, 07 Nov 2022RM 92.5mRM 28.4mRM 7.2m12.8x12.8x3.3x
Wed, 05 Oct 2022RM 87.6mRM 28.4mRM 7.2m12.1x12.1x3.1x
Fri, 02 Sep 2022RM 93.2mRM 28.4mRM 7.2m12.9x12.9x3.3x
Sun, 31 Jul 2022RM 129.2mRM 22.0mRM 1.1m116.6x116.6x5.9x
Tue, 28 Jun 2022RM 104.3mRM 22.0mRM 1.1m94.2x94.2x4.8x
Thu, 26 May 2022RM 86.9mRM 22.0mRM 1.1m78.5x78.5x4x
Price to Earnings Ratio

78.5x


Total Market Cap: RM 86.9mTotal Earnings: RM 1.1mTotal Revenue: RM 22.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Clinical Research and Equipment Industry Price to Earnings3Y Average 14.8x202320242025
Current Industry PE
    There is only one company in the Malaysian Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Revenues have also declined 32% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does Malaysian Clinical Research and Equipment compare with similar industries?

MY Market1.84%
Healthcare-0.31%
Life Sciences-1.89%
Clinical Research and Equipment-1.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MGRC

RM 0.24

Malaysian Genomics Resource Centre Berhad

7D

-9.4%

1Y

-41.5%